Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …
A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …
US researchers are pushing forward with the development of a cheaper, semi-synthetic version of artemisinin, the basis of the most …

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …
Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …
GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …
A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
GlaxoSmithKline has announced a series of measures to help improve medical treatment in poor countries. It has set up an …

In this week’s roundup: Roche answers cancer testing questions, Novartis uses SMS in fight against malaria, UCB goes to Facebook …